Abstract:Background:Bone marrow-derived mesenchymal stem cells (MSCs) have been proved in vitro to inducible differentiate into many kinds of cells of mesenchymal tissues such as osteocytes,chondrocytes, adipocytes,myocytes et al,especially myocardium cells. Recently it was shown that the wall thickness and heart function were improved after MSCs implantation in animal experiments and large-scale clinical trials. But other studies didn’t show that grafted stem cells can bring benefits to heart function in patients with cardiac disease. These therapeutic differences may be rise at least because of lack of visible method to trace in vivo grafted stem cells bio-behaviors such as survive,proliferation,distribution and differentiation. In recent decade an in vivo cellular tracking techniques by using luciferase marker so called BLU have been developed for long-term study of stem cells homing and migration. Bioluminescent imaging ( BLU) technology is a technology to integrate exogenous report luciferase genes into host cells,and express luciferase. This enzyme will give out the visible light when it reacts with its substrate fluorescein under the condition of existing O2 and ATP,to track living cells in real time. In BLU technology the vector for gene transfection is considered a principal because it very closely links to gene transfection efficiency and hence cells lumination. Objective:By using reconstructed-lentivirus vector transfection and bioluminescent imaging techniques to monitor in vivo survival and proliferation and migration of grafted human mesenchymal stem cells (hMSCs) in mice. Methods:Firefly-Luciferase (LUC) -Lentivirus vector were constructed and co-cultured with hMSCs in vitro. Then transfected hMSCs were subcutaneously injected into mice. Either in vitro and in vivo biophotonic imaging of hMSCs were detected by using Xenogen Visible System. Results:1. When multiplicity of infection (MOI) was 100,transfection efficiency of LUC-lentivirus vector could come to (29. 6 ±1. 5)%. Transfected- hMSCs had expressed LUC after 20 successive generation. Indicating this reconstructed lentivirus-LUC-vector has the characteristics of high transfection sensitivity to hMSCs,and high stability for exogenous reporter gene integration and its expression. 2. No morphological and proliferation effect on hMSCs were observed after co- culture with constructed lentivirus vector for 20 generation. This demonstrating that neither lentivirus vector nor exogenous reporter gene has cytotoxicity to targeting cells. 3. Detected in vivo bioluminescence intensity was positively correlated with grafted mass of transfected-LUC hMSCs ( R2 = 0. 9826 ). 4. Since cellular transplantation,in vivo bioluminescence signal bounded injection location were detectable and the signal intensity were linear faded out until to 6th day. Means the survival,homing,proliferation and migration of Firefly-Luciferase gene transfected hMSCs can be quantitatively in vivo monitored in real time. Conclusion: Reconstructed descytotoxicityly lentivirus vector is an effective and safety tool for Firefly-Luciferase gene integrating into hMSCs. Thus by using bioluminescent tracer techniques the phenotype and potential involving homing,proliferation and migration of LUC-transfectied hMSCs can be quantitatively in vivo real-timely monitored.

Use of Bioluminescent Imaging to Assay the Transplantation of Immortalized Human Fetal Hepatocytes into Mice.

A Three-Dimensional Imaging Method for the Quantification and Localization of Dynamic Cell Tracking Posttransplantation

Non-invasive Bioluminescence Imaging of Myoblast-Mediated Hypoxia-Inducible Factor-1 Alpha Gene Transfer

Molecular imaging for tracking transplanted embryonic stem cells in the treatment of acute liver injury

In Vivo Monitoring of Hmscs Stem Cell by Bioluminescent Tracer in Mice

Transplantation of Immortalized Human Fetal Hepatocytes Prevents Acute Liver Failure in 90% Hepatectomized Mice.

Assessing in Vitro Stem‐cell Function and Tracking Engraftment of Stem Cells in Ischaemic Hearts by Using Novel Irfp Gene Labelling

Noninvasive in-vivo tracing and imaging of transplanted stem cells for liver regeneration.

Establishment Of Highly Differentiated Immortalized Human Hepatocyte Line With Simian Virus 40 Large Tumor Antigen For Liver Based Cell Therapy

Noninvasive Evaluation of Liver Repopulation by Transplanted Hepatocytes Using 31P MRS Imaging in Mice.

Bioluminescence Imaging of Transplanted Mesenchymal Stem Cells by Overexpression of Hepatocyte Nuclear Factor4α: Tracking Biodistribution and Survival

Optimization of Mesenchymal Stem Cells (MSCs) Delivery Dose and Route in Mice with Acute Liver Injury by Bioluminescence Imaging

In Vivo Tracing of Transplanted Bone Marrow Mesenchymal Stem Cells with Bioluminescence Imaging

GFP Labeling and Hepatic Differentiation Potential of Human Placenta-Derived Mesenchymal Stem Cells

In Vivo Distribution and Gene Expression of Genetically Modified Hepatocytes after Intrasplenic Transplantation

Immortalization of porcine hepatocyte lines by transfection with simian virus 40 large T antigen and human telomerase reverse transcriptase

Establishment and characterization of immortalized human hepatocyte cell line for applications in bioartificial livers

Decellularized liver matrix as a carrier for the transplantation of human fetal and primary hepatocytes in mice.

An NIR‐II Fluorescence/Dual Bioluminescence Multiplexed Imaging for in Vivo Visualizing the Location, Survival, and Differentiation of Transplanted Stem Cells

In Vivo Bioluminescence Imaging of Transplanted Mesenchymal Stromal Cells and Their Rejection Mediated by Intrahepatic NK Cells

Tracking Transplanted Cells in Live Animal Using Upconversion Fluorescent Nanoparticles